91 related articles for article (PubMed ID: 27245202)
1. HMGI-C suppressing induces P53/caspase9 axis to regulate apoptosis in breast adenocarcinoma cells.
Mansoori B; Mohammadi A; Shirjang S; Baradaran B
Cell Cycle; 2016 Oct; 15(19):2585-2592. PubMed ID: 27245202
[TBL] [Abstract][Full Text] [Related]
2. Neuronal pentraxin II (NPTX2) hypermethylation promotes cell proliferation but inhibits cell cycle arrest and apoptosis in gastric cancer cells by suppressing the p53 signaling pathway.
Xu G; Fan L; Zhao S; OuYang C
Bioengineered; 2021 Dec; 12(1):1311-1323. PubMed ID: 33896384
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of miR-34a Effect on CCND1 mRNA Level and Sensitization of Breast Cancer Cell Lines to Paclitaxel.
Irani S; Paknejad M; Soleimani M; Azam S
Iran Biomed J; 2020 Nov; 24(6):361-9. PubMed ID: 32660221
[TBL] [Abstract][Full Text] [Related]
4. Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro.
Abu N; Akhtar MN; Yeap SK; Lim KL; Ho WY; Zulfadli AJ; Omar AR; Sulaiman MR; Abdullah MP; Alitheen NB
PLoS One; 2014; 9(10):e105244. PubMed ID: 25286005
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of two gastric cancer cell lines induced by fucoxanthin involves downregulation of Mcl-1 and STAT3.
Yu RX; Yu RT; Liu Z
Hum Cell; 2018 Jan; 31(1):50-63. PubMed ID: 29110251
[TBL] [Abstract][Full Text] [Related]
6. The emerging role and mechanism of HMGA2 in breast cancer.
Ma Q; Ye S; Liu H; Zhao Y; Zhang W
J Cancer Res Clin Oncol; 2024 May; 150(5):259. PubMed ID: 38753081
[TBL] [Abstract][Full Text] [Related]
7. Puma- and Caspase9-mediated apoptosis is dispensable for p53-driven neural crest-based developmental defects.
Bowen ME; Mulligan AS; Sorayya A; Attardi LD
Cell Death Differ; 2021 Jul; 28(7):2083-2094. PubMed ID: 33574585
[TBL] [Abstract][Full Text] [Related]
8. Interplay between HMGA and TP53 in cell cycle control along tumor progression.
Meireles Da Costa N; Palumbo A; De Martino M; Fusco A; Ribeiro Pinto LF; Nasciutti LE
Cell Mol Life Sci; 2021 Feb; 78(3):817-831. PubMed ID: 32920697
[TBL] [Abstract][Full Text] [Related]
9. Effect of siRNA-mediated silencing of p53R2 gene on sensitivity of T-ALL cellsto Daunorubicin.
Kiani Ghalesardi O; Zaker F; Ghotaslou A; Boustani H; Rezvani MR; Kiani J; Shahidi M
Gene; 2023 Sep; 880():147622. PubMed ID: 37419428
[TBL] [Abstract][Full Text] [Related]
10. RNA-Seq based genome-wide analysis reveals loss of inter-chromosomal regulation in breast cancer.
Espinal-Enríquez J; Fresno C; Anda-Jáuregui G; Hernández-Lemus E
Sci Rep; 2017 May; 7(1):1760. PubMed ID: 28496157
[TBL] [Abstract][Full Text] [Related]
11. HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition.
Ma Q; Ye S; Liu H; Zhao Y; Mao Y; Zhang W
Front Oncol; 2024; 14():1320887. PubMed ID: 38361784
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma.
De Martino M; Pellecchia S; Decaussin-Petrucci M; Testa D; Meireles Da Costa N; Pallante P; Chieffi P; Fusco A; Esposito F
Cell Cycle; 2023; 22(23-24):2552-2565. PubMed ID: 38165007
[TBL] [Abstract][Full Text] [Related]
13. Emodin prevents renal ischemia-reperfusion injury via suppression of p53-mediated cell apoptosis based on network pharmacology.
Lu H; Xie D; Qu B; Li M; He Y; Liu W
Heliyon; 2023 May; 9(5):e15682. PubMed ID: 37215853
[TBL] [Abstract][Full Text] [Related]
14. High Mobility Group A 1 Expression as a Poor Prognostic Marker Associated with Tumor Invasiveness in Gastric Cancer.
Chang HP; Sun JT; Cheng CY; Liang YJ; Chen YL
Life (Basel); 2022 May; 12(5):. PubMed ID: 35629376
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer.
Mansoori B; Terp MG; Mohammadi A; Pedersen CB; Ditzel HJ; Baradaran B; Gjerstorff MF
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680349
[TBL] [Abstract][Full Text] [Related]
16. Silencing of HMGA2 by siRNA Loaded Methotrexate Functionalized Polyamidoamine Dendrimer for Human Breast Cancer Cell Therapy.
Abedi Gaballu F; Cho WC; Dehghan G; Zarebkohan A; Baradaran B; Mansoori B; Abbaspour-Ravasjani S; Mohammadi A; Sheibani N; Aghanejad A; Ezzati Nazhad Dolatabadi J
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356120
[TBL] [Abstract][Full Text] [Related]
17. [miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2].
Yao Y; Zhang C; Xiong Y; Han B; Gao X; Wang S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1022-1029. PubMed ID: 34308851
[TBL] [Abstract][Full Text] [Related]
18. From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy.
Derakhshani A; Rostami Z; Safarpour H; Shadbad MA; Nourbakhsh NS; Argentiero A; Taefehshokr S; Tabrizi NJ; Kooshkaki O; Astamal RV; Singh PK; Taefehshokr N; Alizadeh N; Silvestris N; Baradaran B
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920054
[TBL] [Abstract][Full Text] [Related]
19. HMGA2 as a Critical Regulator in Cancer Development.
Mansoori B; Mohammadi A; Ditzel HJ; Duijf PHG; Khaze V; Gjerstorff MF; Baradaran B
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33668453
[TBL] [Abstract][Full Text] [Related]
20. circUBAP2 regulates osteosarcoma progression via the miR‑204‑3p/HMGA2 axis.
Ma W; Xue N; Zhang J; Wang D; Yao X; Lin L; Xu Q
Int J Oncol; 2021 Mar; 58(3):298-311. PubMed ID: 33650644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]